TheEdgeResearch
Home / Stocks / AGFAF

Digicann Ventures Inc. (AGFAF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$86,599
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.35
52-Wk Range
0.0002-0.0882
CEO
Nicholas J. Kuzyk
Country
CA
Currency
USD

Digicann Ventures Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $86,599. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -5863.2%. Its beta of 2.35 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.88
Price / Book
-0.01
EV / EBITDA
-1.14
Gross margin
45.1%
Operating margin
-2842.4%
Net margin
-5863.2%
Return on equity
Debt / equity
-0.99
Current ratio
0.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2015-07-14
Headquarters
Vancouver, BC, CA
About Digicann Ventures Inc.

Digicann Ventures Inc. is actively involved in the cannabis industry, conducting its operations through its own structure and its various subsidiaries. This company, founded in 2004, underwent a corporate identity change in August 2023, rebranding from its previous name, Agra Ventures Ltd., to its current designation. Its primary administrative offices are situated in Vancouver, Canada.

Comparable companies

Digicann Ventures Inc. is most often compared with the following Healthcare names:

ACHKFALSECSTFLAXAFLTTSFNHIQPLSISBUDFVCBDQVEGGD
More research on AGFAF
AGFAF technical analysis AGFAF TheEdge Score Compare against peers
Open full interactive analysis & DCF →